Pacific Biosciences Of California (PACB) Current Deferred Revenue (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Current Deferred Revenue of $16.3 million for Q1 2026, up 7.15% year-over-year from $15.2 million in Q1 2025, and up 2.47% quarter-over-quarter from $15.9 million in Q4 2025.
Pacific Biosciences Of California (PACB) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Current Deferred Revenue history runs 17 years deep, the most recent figure standing at $16.3 million for Q1 2026.
- In Q1 2026, Current Deferred Revenue rose 7.15% year-over-year to $16.3 million; the TTM figure through Mar 2026 stood at $16.3 million (up 7.15% YoY), while the FY2025 annual figure was $15.9 million, up 14.95% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $16.3 million, up from $15.9 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $32.7 million in Q1 2023, with the low at $12.7 million in Q1 2022.
- The 5-year median for Current Deferred Revenue is $22.4 million (2023), against an average of $21.5 million.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue surged 236.52% in 2022, then sank 46.42% in 2023.
- Pacific Biosciences Of California's Current Deferred Revenue stood at $30.5 million in 2022, then tumbled by 46.42% to $16.3 million in 2023, then retreated by 15.16% to $13.9 million in 2024, then increased by 14.95% to $15.9 million in 2025, then increased by 2.47% to $16.3 million in 2026.
- Business Quant data shows PACB's Current Deferred Revenue at $16.3 million in Q1 2026, $15.9 million in Q4 2025, and $16.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.62 Bn | 197.02 Bn | 7.27 Bn |
| 2 | Stryker | 126.48 Bn | 123.00 Bn | 4.50 Bn |
| 3 | Medtronic | 119.39 Bn | 110.17 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.22 Bn | 73.68 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.61 Bn | 47.35 Bn | 1.35 Bn |
| 6 | Dexcom | 34.96 Bn | 33.02 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.73 Bn | 31.62 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.21 Bn | 22.89 Bn | 4.55 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 420.94 Mn | 184.06 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.10 Mn |
| Mar 31, 2026 | 16.33 Mn |
| Dec 31, 2025 | 15.94 Mn |
| Sep 30, 2025 | 16.05 Mn |
| Jun 30, 2025 | 14.86 Mn |
| Mar 31, 2025 | 15.24 Mn |
| Dec 31, 2024 | 13.86 Mn |
| Sep 30, 2024 | 22.80 Mn |
| Jun 30, 2024 | 24.90 Mn |
| Mar 31, 2024 | 23.40 Mn |
| Dec 31, 2023 | 16.34 Mn |
| Sep 30, 2023 | 22.40 Mn |
| Jun 30, 2023 | 25.00 Mn |
| Mar 31, 2023 | 32.70 Mn |
| Dec 31, 2022 | 30.50 Mn |
| Sep 30, 2022 | 30.69 Mn |
| Jun 30, 2022 | 32.08 Mn |
| Mar 31, 2022 | 12.73 Mn |
| Dec 31, 2021 | 10.98 Mn |
| Jun 30, 2021 | 9.53 Mn |